Accueil   Diary - News   All news New members

New members

 

Our mission: To provide the highest quality of patient care by supporting research and medical teams everyday with innovative technologies.

 

Institut Georges Lopez, more often referred to as IGL, is a medical technology company specializing in the care of explanted organs and tissues.

.

IGL teams design, manufacture and market electromedical devices and their sterile consumables, as well as organ preservation solution. Classified as drugs or medical devices, these solutions are intended for the treatment of patients with chronic organ diseases.

 

With years of expertise and experience, IGL is proud to be regarded as a key player in its domain.

IGL is headquartered in Lyon area (France), and consists of a network of subsidiaries located worldwide. This means we are never far from our customers and so can help them to meet their local challenges.

 

 

 

 

 

 

 

Thermo Fisher Scientific is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive services.

 

 

 

 

Weezion is developing a rapid in vitro diagnostic (IVD) solution for microbial infections in the blood that provides both pathogen identification and antibiotic resistance profile in less than 90 minutes. 

 

This rapid diagnosis ensures that targeted antibiotic therapy can be initiated earlier and consequently improves the management of sepsis. This rapid diagnostic method also contributes to the fight against antibiotic resistance, one of the WHO's priorities targeted in its 2015 global action plan.

 

The Weezion Dx technology is based on a proteomic approach and a disruptive process of targeted mass spectrometry, patented in 2015 by one of the founders.

 

Weezion is the valuation vehicle for the IdBioriv research project, granted in 2019 as one of the selected projects of the French Investments for the Future Program.

 

La startup was founded by professors F VANDENESCH from HCL, J LEMOINE from Claude Bernard University and H BROCHETTE as CEO.

 

 

 

StrainChem is specialized in organic and therapeutic chemistry, adapted in environmental standards. She developed two innovative technologies for peptide synthesis that is more efficient, economical, and environmentally friendly than traditional liquid- and solid-phase methods. Others sustainable technologies to accesses biopolymers are underway. StrainChem also produces libraries of tailor-made molecules.

 

 

 

 

Neovision is a company specialized in artificial intelligence. Its ambition is to make artificial intelligence accessible to all. It provides its customers with tailor-made and turnkey AI solutions through personalized support.

 

Neovision constantly monitors the latest advances and invests in R&D on promising topics, in order to provide its customers with high-performance, state-of-the-art innovations.

 

Through its service offers, Neovision supports you in integrating AI into your company by relying on an efficient and proven methodology.

In addition to its customized training offer, Neovision will help you define your AI strategy, and then design and validate the best solution for you. Finally, Neovision develops and industrializes the solution to facilitate its integration and generate a real ROI.

 

Capitalizing on its experience and recognized expertise in computer vision, Neovision offers mature technologies for image recognition, OCR and activity characterization.

In addition, it also offers you data analysis software tools which will help you analyze your data and accelerate your AI projects.